Acasti Pharma Receives Certificate for European Patent from European Patent Office
January 09, 2019 at 01:00 pm
Acasti Pharma Inc. announced a Certificate for a European Patent has been issued by the European Patent Office. The granted patent is valid until 2030 and relates to a concentrated phospholipid composition and method of using the same for modulating blood lipids. This patent was validated in Belgium, Switzerland, Germany, Denmark, Spain, Finland, France, United Kingdom, Italy, Netherlands, Norway, Portugal and Sweden.